<?xml version="1.0" encoding="UTF-8"?>
<ref id="B38-pathogens-08-00176">
 <label>38.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Roccatello</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Sciascia</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Baldovino</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Rossi</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Alpa</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Naretto</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Di Simone</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Menegatti</surname>
    <given-names>E.</given-names>
   </name>
  </person-group>
  <article-title>Improved (4 plus 2) rituximab protocol for severe cases of mixed cryoglobulinaemia: A 6-year observational study</article-title>
  <source>Am. J. Nephrol.</source>
  <year>2016</year>
  <volume>43</volume>
  <fpage>251</fpage>
  <lpage>260</lpage>
  <pub-id pub-id-type="doi">10.1159/000445841</pub-id>
  <pub-id pub-id-type="pmid">27161362</pub-id>
 </element-citation>
</ref>
